PETER MELLO: Open Payments
NPI 1316210545 · PROVIDENCE, RI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$801 in 33 payments from 5 companies in 2025. Trend: 2023 $107 · 2024 $110 · 2025 $801
Food & beverage: $801
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $288 |
| GENZYME CORPORATION | 7 | $234 |
| Regeneron Healthcare Solutions, Inc. | 8 | $214 |
| Genentech USA, Inc. | 2 | $35 |
| GlaxoSmithKline, LLC. | 1 | $30 |
Products named: DUPIXENT, LINZESS, CREON, Xolair, NUCALA.
Industry payments across RI — which companies pay providers there.
